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Introduction: The results from the physical training and cancer randomized controlled
trial (Phys-Can RCT) indicate that high intensity (HI) strength and endurance training
during (neo-)adjuvant cancer treatment is more beneficial for cardiorespiratory fitness
(CRF, measured as peak oxygen uptake [VO2 peak]) than low-to-moderate intensity
(LMI) exercise. Adherence to the exercise intervention and demographic or clinical
characteristics of patients with breast cancer undergoing adjuvant treatment may
moderate the exercise intervention effect on VO2 peak. In this study, the objective
was to investigate whether baseline values of VO2 peak, body mass index (BMI), time
spent in moderate- to vigorous-intensity physical activity (MVPA), physical fatigue, age,
chemotherapy treatment, and the adherence to the endurance training moderated the
effect of HI vs. LMI exercise on VO2 peak.
Materials and Methods: We used data collected from a subsample from the PhysCan RCT; women who were diagnosed with breast cancer and had a valid baseline and
post-intervention VO2 peak test were included (n = 255). The exercise interventions from
the RCT included strength and endurance training at either LMI, which was continuous
endurance training at 40–50% of heart rate reserve (HRR), or at HI, which was interval
training at 80–90% of HRR, with similar exercise volume in the two groups. Linear
regression analyses were used to investigate moderating effects using a significance
level of p < 0.10. Statistically significant interactions were examined further using the
Johnson–Neyman (J-N) technique and regions of significance (for continuous variables)
or box plots with adjusted means of post-intervention VO2 peak (for binary variables).
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Results: Age, as a continuous variable, and adherence, dichotomized into < or > 58%
based on median, moderated the effect of HI vs. LMI on CRF (B = −0.08, 95% CI
[−0.16, 0.01], pinteraction = 0.06, and B = 1.63, 95% CI [−0.12, 3.38], pinteraction =
0.07, respectively). The J-N technique and regions of significance indicated that the
intervention effect (HI vs. LMI) was positive and statistically significant in participants
aged 61 years or older. Baseline measurement of CRF, MVPA, BMI, physical fatigue, and
chemotherapy treatment did not significantly moderate the intervention effect on CRF.
Conclusion: Women with breast cancer who are older and who have higher adherence
to the exercise regimen may have larger effects of HI exercise during (neo-)adjuvant
cancer treatment on CRF.
Keywords: cardiorespiratory fitness (CRF), breast cancer, moderators, intensity, age, exercise adherence,
endurance and strength training

INTRODUCTION

clinical or demographic characteristics in the meta-analysis. In
a meta-analysis including healthy, young to middle-aged adults,
HI interval training produced larger improvements in CRF
compared to LMI continuous endurance training, with greater
benefits for the less fit adults, those with a lower baseline CRF
(Milanovic et al., 2015). Objective measures of baseline physical
activity level and VO2 peak before an exercise intervention may
(partly) represent a person’s physical activity and exercise history
and, therefore, are relevant to consider as the moderators of
the intervention effect on CRF (Zeiher et al., 2019). In addition
to low CRF at baseline, people with a history of low physical
activity or exercise levels may respond differently to HI or LMI
exercise. As people get older, physical activity levels and CRF
decrease (Jackson et al., 2009; Westerterp, 2018), and in the
general adult population, age is found to be a determinant for
CRF (Zeiher et al., 2019). Furthermore, body mass index (BMI)
has also been found to be associated with CRF in the healthy
population (Zeiher et al., 2019).
Additionally, chemotherapy may also directly and indirectly
influence the exercise-induced change in CRF (Lakoski et al.,
2013; Wiestad et al., 2020). Physical fatigue may affect how
well people manage to perform the prescribed exercise and
consequently indirectly affect the exercise-induced change in
CRF (Christensen et al., 2018).
The objective of this study was to investigate whether baseline
values of VO2 peak, BMI, time spent in moderate- to vigorousintensity physical activity (MVPA), physical fatigue, age,
chemotherapy treatment, and the adherence to the endurance
training moderated the effect of 6 months of HI vs. LMI exercise
during breast cancer treatment on VO2 peak.

Although improved diagnostic techniques and treatments have
increased the survival rates in the recent decades (Torre et al.,
2016; Bray et al., 2018), individuals with a history of cancer
struggle with reduced physical function and quality of life due
to various side effects (Banzer et al., 2014). Women treated
for breast cancer often experience impaired cardiorespiratory
fitness (CRF) (Jones et al., 2012; Peel et al., 2014), which is
associated with increased cardiovascular (Jones et al., 2007, 2012)
and cancer-specific mortality (Schmid and Leitzmann, 2015).
In both healthy individuals and in patients with cardiovascular
disease, CRF, measured as peak oxygen uptake (VO2 peak), is an
important clinical predictor of overall mortality (O’Neill et al.,
2005; Kodama et al., 2009; Ekblom-Bak et al., 2019).
The results from the physical training and cancer randomized
controlled trial (Phys-Can RCT) indicated that high intensity
(HI) strength and endurance training during cancer treatment
are associated with more beneficial changes in VO2 peak,
compared to low-to-moderate intensity (LMI) exercise
(Demmelmaier et al., 2021). When comparing two different
exercise intensities, adherence to the exercise intervention(s)
is an important factor for understanding the cause-and-effect
relationship (Hecksteden et al., 2018). In the Phys-Can RCT,
adherence to the endurance training was higher in the LMI
group than in the HI exercise group (Demmelmaier et al., 2021).
Consequently, the effect of HI vs. LMI exercise on CRF may
be moderated by adherence to the intervention, but also by
demographic or clinical characteristics of the patients (Courneya
et al., 2004; Jackson et al., 2009; Shang et al., 2012; Lakoski et al.,
2013; Buffart et al., 2018; Sweegers et al., 2019; Zeiher et al., 2019;
Wiestad et al., 2020).
In a meta-analysis of individual patient data, larger effects of
exercise interventions on CRF were found in younger patients
(Sweegers et al., 2019), and in patients with higher CRF prior
to the exercise intervention (Buffart et al., 2018). However, this
meta-analysis did not examine whether exercise response to
different intensities varied in various subgroups (Buffart et al.,
2018; Sweegers et al., 2019). Therefore, it is not clear whether
the observed intervention effect (HI vs. LMI) on CRF varies by
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MATERIALS AND METHODS
Design and Participants
The study protocol (Berntsen et al., 2017) and the primary study
results from the Phys-Can RCT, a multicenter 2 × 2 factorial
design trial, have been published previously (Demmelmaier et al.,
2021), and this study is based on secondary analyses of data from
this study. Phys-Can RCT was approved by the Regional Ethical
Review Board in Uppsala (Dnr 2014/249) and registered in
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FIGURE 1 | The hypothesized moderation model. Intervention effect (mean difference in change between low-to-moderate intensity (LMI) and high intensity (HI)
training) on peakimal oxygen uptake (VO2 peak) post-intervention. The potential moderator variables investigated were baseline age, body mass index (BMI),
cardiorespiratory fitness (CRF), hours in moderate-to-vigorous physical activity (MVPA), physical fatigue, chemotherapy treatment (yes/no), and adherence to the
endurance training. Each of the potential moderator variables was included in the regression model one at a time, resulting in a total of seven models.

ClinicalTrials.gov (TRN = NCT02473003, Oct 2014) (Berntsen
et al., 2017; Demmelmaier et al., 2021). The recruitment process
has been described previously in detail (Demmelmaier et al.,
2021). Briefly, eligible patients who were newly diagnosed with
breast, colorectal, or prostate cancer and scheduled to undergo
(neo-)adjuvant cancer treatment were recruited at university
hospitals in three cities of Sweden (Lund/Malmö, Linköping,
and Uppsala) between March 2015 and April 2018. Participants
were stratified by study site and randomized to one of four
intervention groups: HI vs. LMI exercise with or without
additional behavioral change support. Exclusion criteria were
stage IIIb–IV breast cancer, inability to perform basic activities
of daily living, cognitive disorders, severe psychiatric disease, or
other disabling conditions that might contraindicate HI exercise,
treatment for an additional ongoing malignant disease, and BMI
< 18.5 kg/m2 or pregnancy.
For this study, only patients with breast cancer and a VO2 peak
test that met the criteria for accepted tests at baseline and
post-intervention were included, resulting in a total number
of 255 participants. All measurements and questionnaires were
completed before and after the exercise intervention.

performed their repetitions alternating between 3 sets × 12
repetitions and 3 sets × 20 repetitions until 50% of maximum.
The endurance training for the HI exercise groups consisted
of two times weekly interval training at 80–90% of heart rate
reserve (HRR) during the 2-min-long intervals with 1 min
of “rest” in between intervals, with the number of intervals
progressed from 5 to 10 over the course of the program. In
the LMI groups, 150 min of continuous exercise at 40–50% of
HRR was prescribed weekly. The endurance training mode was
chosen by participants according to their preference and could
be running, cycling, walking uphill, or any other endurancebased activity. After a familiarization period introducing the
heart rate monitor and how to use the Borg Scale (Borg,
1970) to monitor exercise intensity, the home-based endurance
training under weekly guidance by a coach began. Half of the
participants received additional support to facilitate adherence
to the respective exercise programs and to maintain physical
activity levels after the completion of the interventions. This
behavioral change support included in the Phys-Can RCT has
been described previously in detail (Demmelmaier et al., 2021).

Measurement of Cardiorespiratory Fitness

Exercise Interventions

The main outcome in this study, CRF, was measured in exercise
laboratories as VO2 peak with gas exchange. A full description
of methods, criteria, and the equipment used for measuring
VO2 peak in the Phys-Can RCT, can be found elsewhere (Bjørke
et al., 2020). Briefly, participants walked or ran to exhaustion on
a treadmill using a modified Balke protocol (Edvardsen et al.,
2013). For this analysis, only the tests meeting two of the three
following criteria for an accepted exercise test were included:
(a) the tester judged the test as maximal using their subjective
evaluation of body language, facial expression, hyperventilation,
and other signs reflecting that a maximal effort had been given;
(b) a Borg rating of perceived exertion, (Borg et al., 1987)

The exercise program has been described in detail in previous
publications (Berntsen et al., 2017; Demmelmaier et al., 2021).
Briefly, all participants performed supervised strength training
and home-based endurance training for 6 months while
undergoing (neo-)adjuvant cancer treatment. The resistance
training prescription in all four groups consisted of six machinebased exercises performed two times a week, with different
intensity, sets, and repetitions based on intensity group. In
the HI exercise groups, participants performed their repetitions
alternating between 3 sets × 6 repetitions maximum (RM) and
3 sets × 10 RM until failure. In the LMI groups, participants
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TABLE 1 | Baseline characteristics of participants with breast cancer in Phys-Can
RCT. Data are presented as mean (±SD) or n (%).

TABLE 2 | Results of the analyses examining potential moderators of HI vs. LMI
exercise on VO2 peak.

Characteristic

Model

LMI (n = 127)

HI (n = 128)

Potential moderator
variable

binteraction

95% CI

p-value

Study site, n (%)
Linköping

30 (24)

24 (19)

1

Age, years

−0.08

−0.16, 0.01

0.06

Lund

56 (44)

54 (42)

2

−0.04

−0.24, 0.15

0.65

Uppsala

41 (32)

50 (39)

BMI, weight in
kg/height in m2

53 (10)

55 (11)

3

Physical fatigue, MFI

−0.01

−0.23, 0.21

0.94

4

Chemotherapy
treatment (yes/no)

0.03

−1.77, 1.83

0.97

Age, years, mean (SD)
Living with a partner, n (%)

99 (78)

95 (74)

Completed university, n (%)

90 (71)

83 (65)

Sick-leave, n (%)
100% sick-leave
75, 50, or 25% sick-leave

49 (39)

46 (36)

7 (6)

9 (7)

Weight status, n (%)
BMI – normal (18.5–24.9)

65 (51)

77 (60)

BMI – overweight (25–29.9)

49 (39)

32 (25)

BMI – obesity (≥ 30)

13 (10)

19 (15)

Current smoker, n (%)

6 (2)

0 (0)

Chemotherapy

89 (70)

84 (66)

No chemotherapy

38 (30)

44 (34)

61 (19)

64 (20)

87 (14)

89 (13)

Physical fatigue, MFI, mean (SD)

12 (4)

12 (4)

Kinesiophobia, mean (SD)

23 (5)

23 (5)

MVPA, hours/day, mean (SD)

1.3 (1.0)

1.3 (0.9)

VO2 peak (ml/kg/min), mean (SD)

31.3 (7.1)

31.5 (7.3)

−0.61

−1.57, 0.34

0.21

0.09

−0.03, 0.21

0.15

7

Exercise adherence
(</> median
adherence)

1.63

−0.12, 3.38

0.07

at least 3.0 metabolic equivalent task values (Garber et al., 2011).
Weekly time spent in MVPA levels was calculated by summing
minutes for each valid day on which the criterion for MVPA
was met.
The calculation methods for exercise adherence have been
described in detail in previous publications (Demmelmaier
et al., 2021) and in accordance with previous research
(Nilsen et al., 2018). Briefly, exercise adherence was calculated
as performed exercise divided by prescribed exercise. The
calculation represented exercise volume (frequency, intensity,
and time) and resulted in one value (0–100%) for resistance
training and one value (0–100%) for endurance training for each
participant. In this study, the variable representing adherence
to the endurance training is included. When adherence to the
endurance training was included by statistical or/and illustrative
purposes, the median was used to dichotomize into two groups,
because of the non-normal distribution of the variable.

EORTC QLQ C30, mean (SD)
Physical function

MVPA, hours/wk
Baseline CRF
(VO2 peak, ml/kg/min)

BMI, body mass index; MFI, Multidimensional Fatigue Inventory; MVPA, moderate to
vigorous physical activity; treatment, cytostatic vs. no cytostatic; CRF, cardiorespiratory
fitness. Median adherence = 58%. Significance level was set to p < 0.10 for
further exploration.

Treatment, n (%)

Global health status/QoL

5
6

BMI, body mass index; EORTC QLQ C30, European Organization for Research and
Treatment of Cancer, quality of life of cancer patients; QoL, quality of life; MFI,
Multidimensional Fatigue Inventory; Tampa, The Tampa Scale of Kinesiophobia; MVPA,
moderate- to vigorous-intensity physical activity; VO2 peak, peak oxygen uptake (ml per
kilogram per min).

rating ≥ 17; and (c) respiratory exchange ratio (RER) ≥ 1.1
(Bjørke et al., 2020).

Assessment of Potential Moderators

Statistical Analyses

Demographic and clinical variables were collected by selfreported validated questionnaires and through medical records.
All of the assessment methods have been described in
previous publications (Berntsen et al., 2017; Bjørke et al., 2020;
Demmelmaier et al., 2021). Briefly, health-related quality of life
was assessed with the European Organization for Research and
Treatment of Cancer (EORTC) QLQ-C30, range 0 (low quality of
life) to 100 (high quality of life) (Aaronson et al., 1993). Physical
fatigue was assessed with the Multidimensional Fatigue Inventory
(MFI) (Smets et al., 1995) with a subscale ranging from 4 (low
fatigue) to 20 (high fatigue).
Physical activity level at baseline was assessed with a
SenseWear Armband Mini (SWA), a tri-axial monitor previously
validated in cancer survivors (Cereda et al., 2007). The
Professional 8.1 Software was used to calculate SWA wear time
and minutes spent in MVPA, using the established cutoff value of

Except for illustrations of figures, all statistical analyses were
performed using the Statistical Package for the Social Sciences
version 25.0 (SPSS, IBM Corp. Released 2017. IBM SPSS Statistics
for Windows, version 25.0. Armonk, New York, USA).
Baseline descriptive including demographic, clinical, or
behavioral characteristics is presented as mean and standard
deviation (SD) for continuous variables and proportions as
number (n) and percentage (%) for categorical variables.
Continuous moderators were kept as continuous if the
variables were normally distributed (by visual inspection of
plots) and dichotomized if not. Linear regression analyses were
used to investigate potential moderators of the effect of HI vs.
LMI exercise on CRF (refer to Figure 1). In the model, postintervention VO2 peak was regressed on the intervention (HI vs.
LMI exercise) while adjusting for baseline VO2 peak. Study site
was included as a covariate in the models, due to the possibility
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FIGURE 2 | Johnson–Neyman plot showing the simple slope (with the 95% confidence intervals) of age on exercise intensity on post-intervention VO2 peak. Colored
area represents the region of significance (p < 0.05).

moderator. Dichotomization of continuous variables was carried
out using median-split or by cut points derived through J-N plots,
which were made as the preferable choice. These figures related
to the binary variables were made using GraphPad Prism, version
7.00 for Windows (GraphPad Software, La Jolla California,
USA, www.graphpad.com).

that patients from the three sites may have been receiving
some variations regarding treatment regimes, test-personnel,
and coaches. Moderating effects were examined by adding the
moderator variable and its interaction term with the intervention
variable into the regression model. Because the interaction effects
were exploratory and intended to generate hypotheses for future
research, we used an alpha level of 0.10 for the interaction terms
(Durand, 2013). The results are presented as unstandardized
regression coefficients (b) and 95% CI.
Models with continuous moderators were estimated using the
PROCESS macro-version 4.0 for SPSS (Hayes, 2022). PROCESS
uses ordinary least squares regression analysis when predicting
continuous variables and can be used to probe and visualize
interactions using the Johnson–Neyman (J-N) technique (Lin,
2020). The J-N technique allows the assessment of whether
and how a continuous variable moderates the relationship
between exercise intensity and VO2 peak after the intervention
by indicating a “region of significance,” which is the case if the
upper and lower CIs are completely below or above zero. A J-N
plot was made by using the coefficients of the regression model in
Microsoft R Excel R for Microsoft 365, version 2202 to visualize
the moderated effect of the intervention (HI vs. LMI exercise)
on VO2 peak.
For visualizations of statistically significant binary moderators
such as chemotherapy treatment, the estimated margin of means
of VO2 peak post-intervention with adjustment for baseline
VO2 peak and study site was reported within subgroups of the

Frontiers in Sports and Active Living | www.frontiersin.org

RESULTS
Baseline characteristics of the participant with breast cancer with
a valid pre- and post-intervention VO2 peak test, reported for the
LMI and the HI group, are presented in Table 1.

Potential Moderating Variables
The regression coefficients of each of the interaction terms
with 95% confidence intervals (CIs) are presented in Table 2 (a
complete table is presented in the Supplementary Table S1). Age
moderated the effect of HI vs. LMI exercise on CRF (B = −0.08,
95% CI [−0.16, 0.01], pinteraction = 0.06). The J–N plot illustrated
that the intervention effect (HI vs. LMI exercise) was positive, in
favor of HI, and statistically significant in patients aged 61 years
or older, n = 68, as visualized in the colored area in the plot
(Figure 2), whereas the intervention effect was not statistically
significant in patients younger than 61 years, n = 187. These
results are further visualized in Figure 3, where the adjusted
post-intervention VO2 peak within LMI and HI exercise groups
and within above and below 61 years is presented. The mean
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exercise adherence in women aged ≤61 years was 65% (SD
32) and 52% (SD 32) for the LMI and HI exercise groups,
respectively. For patients aged ≥62, the mean exercise adherence
was 66% (SD 31) and 42% (SD 30) for the LMI and HI exercise
groups, respectively (Supplementary Figure S1). Chemotherapy
treatment was administered in 75% of the younger women and in
49% of the older women.
Adherence to the endurance training moderated the
intervention effect of HI vs. LMI exercise on CRF (B = 1.63, 95%
CI [−0.12, 3.38], pinteraction = 0.07), with larger effects in patients
who adhered above 58% (Figure 4).
Baseline CRF, MVPA, BMI, physical fatigue, and
chemotherapy treatment did not significantly moderate
the effect of HI vs. LMI exercise on CRF (Table 2 and
Supplementary Table S1).
FIGURE 3 | VO2 peak post-intervention below and over the age cutoff (61
years), presented within the two intensity groups LMI (blue triangle) and HI (red
squares). Means are adjusted for VO2 peak at baseline and study site is
included as covariate.

DISCUSSION
Both age and adherence to the endurance training were found to
moderate the intervention effect of HI vs. LMI exercise on CRF
with significant beneficial effects in patients aged 61 years or older
and in patients with adherence >58%.
Demographic and clinical variables did not moderate the
intervention effect of HI vs. LMI exercise on CRF.
Our finding that age moderated the intervention effect on
CRF in a cancer population is in line with the previous
studies (Courneya et al., 2008; Sweegers et al., 2019). However,
these studies did not investigate the modifying role of age
in combination with exercise intensity (Courneya et al., 2008;
Sweegers et al., 2019), making it less relevant for comparison
with the findings in this study. Nevertheless, the general trend in
both of these studies was that young patients responded better
to the intervention than older patients irrespective of exercise
intensity. In a meta-analysis, Sweegers et al. (2019) reported the
intervention effect to be significantly larger when compared to
usual care for patients younger than 50 years (Sweegers et al.,
2019). Additionally, in the RCT published by Courneya et al.
(2008) patients younger than 50 years were found to have a larger
improvement in their VO2 peak after performing aerobic exercise
training compared to usual care. This was noted in comparison
with women above 50 years, in which there was no difference
between exercise and usual care (Courneya et al., 2008). We
found that this moderator effect of age is not only the case when
comparing exercise vs. usual care but also for HI vs. LMI exercise.
This means that older women may achieve a more beneficial
change in their CRF if they exercise at HI, compared to LMI.
The difference in intervention effects by age could not be
explained by the differences in adherence to the endurance
training, as women aged above 61 years had markedly lower
average adherence in the HI exercise group (43%) compared to
the LMI exercise group (66%). The same trend was observed for
women under the age of 61 years, but adherence to HI was higher
in the younger group: 52% in the HI exercise group and 65% in
the LMI exercise group (Supplementary Figure S1).
Older women have lower CRF compared to younger women
(Jackson et al., 2009). When adding the literature related to the
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FIGURE 4 | VO2 peak post-intervention below and over median adherence to
the endurance training (58%), presented within the two intensity groups LMI
(blue triangle) and HI (red squares). Means are adjusted for VO2 peak at
baseline and study site is included as covariate. * = p < 0.01.

fact that less fit adults may achieve improvements in CRF at
a relatively lower exercise intensity level than more fit adults
(Milanovic et al., 2015), our findings are somewhat contradictory
to the existing literature. Our results indicate that it is the less
fit women (the oldest) who gain CRF benefits from exercising
at higher intensities than lower intensities. For women younger
than 61 years, the exercise intensity did not appear to affect the
CRF results to the same degree. Importantly, CRF is relative to
age and should be reported as a percentage of the age predicted
VO2 peak. There were no differences between the young and old
groups, with the young group (mean age 49 years) averaging 84%
of predicted VO2 peak, and the old group (mean age 68 years)
averaging 85% of predicted VO2 peak, when using data from the
Norwegian HUNT study as a reference for healthy women in
different age groups (Loe et al., 2013).
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reported in men with prostate cancer (Nilsen et al., 2018).
We found that younger women have a smaller difference
in adherence between intensity groups compared to the
oldest women. This observation, in combination with older
age having a stronger intervention effect, underlines the
importance of including strategies to optimize adherence in the
oldest participants.
In total, the finding related to exercise adherence substantiates
the notion that participants need to perform the training with a
certain diversity in intensity to produce a difference in effect on
VO2 peak. HI exercise is most beneficial for improving VO2 peak
in patients undergoing treatment for cancer, given that the
patients can manage to complete the HI training.
The fact that demographic and clinical variables did not
moderate the intervention effect of HI vs. LMI exercise on CRF
implies that if women have variations within baseline values of
BMI, MVPA, CRF, or physical fatigue and are scheduled for
chemotherapy treatment or not, we cannot specify one exercise
intensity over the other. Consequently, women may choose either
LMI or HI exercise according to their own preferences.

We did not find chemotherapy treatment as a binary variable
(yes/no) to be a moderator of the intervention effect in this
study. Although others have found more intense treatment such
as chemotherapy in addition to radiotherapy, to moderate the
intervention effect when compared to a control group (Kalter
et al., 2015), our study may have been underpowered to detect
a moderation effect between two exercise intensities. The fact
that women aged above 61 years in Phys-Can were more seldom
prescribed breast cancer treatment including chemotherapy
(49 vs. 75%) is relevant to mention in relation to our finding of
age being a moderator for the intervention effect on CRF. That
older patients less often receive chemotherapy agrees with other
studies as well (August et al., 1994; Partridge, 2021).
Interestingly, although chemotherapy treatment itself did
not moderate the intervention effect, the fact that the older
women received less chemotherapy may be a part of the
explanation for why age was found to moderate the intervention
effect on VO2 peak in favor of HI exercise. Although cancer
itself in combination with surgery, radiotherapy, and endocrine
treatment can impair CRF, the chemotherapy-induced toxicity
caused by the generation of reactive oxygen species and the
induction of cardiac myocyte apoptosis or necrosis is known
to be the most harmful treatment, especially if the therapy is
anthracycline-based (Chen et al., 2007; Shi et al., 2011; Suter
and Ewer, 2013). There may be other mechanisms for why
chemotherapy impairs CRF, for example, anemia, dehydration,
and impairment of pathways within muscle cells which again
impair the O2 extraction from the blood to the muscles (Jones
et al., 2009; Christensen et al., 2018). Consequently, it may be
more physiologically difficult for younger women to gain the
beneficial effect of HI vs. LMI exercise because more of them
receive chemotherapy.
Another aspect to acknowledge relating to the finding of age
as a moderator is the wide CIs, especially for the youngest and
oldest participants, due to the few participants (in the oldest
and youngest age) and the large variations in VO2 peak. Wide
CIs indicate that the estimates are less precise, and when adding
the observation (in the J-N plot) that the lower limit of the CI
is just above zero, the finding of age as a moderator should
be interpreted with caution. In summary, there is a strong
indication that age may moderate the effect of the intervention
on VO2 peak after being randomized to HI or LMI exercise for 6
months during breast cancer treatment. However, we suspect this
finding to be somewhat disturbed by variations in chemotherapy
treatment across the age span.

Strengths and Limitations
Regarding the exercise intervention in the Phys-Can RCT, there
was thorough monitoring of exercise frequency, intensity, type,
and duration to ensure that the exercise volume was similar
in the two intensity groups. Still, it should be mentioned that
the reporting method did differ between HI and LMI exercise
groups. In the LMI group, we could not calculate adherence to
frequency, intensity, time, and type of endurance training, refer
to Mazzoni et al. (2020) for a discussion related to adherence
reporting (Mazzoni et al., 2020). Another strength of the PhysCan RCT was that the participants walked or ran on a treadmill
when performing the VO2 peak test, which is the gold standard
and a direct method to measure CRF. We also used criteria for
including or excluding valid and accepted tests.
To our knowledge, we have performed the first investigation
of potential moderators for this specific intervention effect
(HI vs. LMI strength and endurance training) on CRF in
women undergoing (neo-)adjuvant breast cancer treatment. By
investigating these potential moderators, we were able to identify
possible subgroups of patients with breast cancer who could
benefit most from exercising at HI vs. LMI. Our findings
that many of the investigated variables do not moderate the
intervention effect, according to being randomized to HI or LMI
exercise, suggest that most women may choose their preferable
exercise intensity. The difference in CRF is not large between
the LMI and HI exercise groups, although the HI group seems
to benefit more than the LMI group (Demmelmaier et al.,
2021). However, among those with higher adherence, a larger
intervention effect was observed for the HI exercise group
compared to the LMI group.

Adherence to the Endurance Training
Adherence to the endurance training was found to moderate
the intervention effect on VO2 peak, where women who adhered
above the median level had a significantly higher VO2 peak if they
had been performing HI exercise, compared to LMI exercise.
In the Phys-Can RCT (Demmelmaier et al., 2021), adherence
to the endurance training was higher in the LMI exercise
group compared to the HI group and also confirmed when
including only the women with breast cancer, as in this
study (Supplementary Figure S1). Higher adherence to an
intervention including lower exercise intensity has also been
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CONCLUSION
The primary finding in this study was that age moderated
the intervention effect, and more specifically, women who are
diagnosed with breast cancer when they are older may reap
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the final manuscript. AS: advising regarding statistical matters
and editing the final manuscript. KN: editing and feedbacks on
the manuscript. SB: conceptualization, feedbacks and discussions
throughout the whole writing process, and editing the final
manuscript. All authors contributed to the article and approved
the submitted version.

greater benefits to their CRF from HI exercise than LMI
exercise during (neo-)adjuvant cancer treatment. Adherence to
the endurance training is important for achieving a beneficial
change in CRF of exercising at HI, compared to LMI. Therefore,
strategies to improve exercise adherence in the population
of women undergoing (neo-)adjuvant breast cancer treatment
are important.
Baseline levels of BMI, MVPA, CRF, and physical fatigue, in
addition to chemotherapy treatment, do not seem to moderate
the intervention effect on CRF by exercising for 6 months at LMI
levels vs. HI levels during (neo-)adjuvant breast cancer treatment.
Therefore, if women have variations within these variables, we
cannot advise either of the exercise intensities over the other;
consequently, women may choose either LMI or HI exercise
according to their own preferences.
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